A.R.T. Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,526
| Closed | -$401K | – | 1621 |
|
|
2019
Q3 | $401K | Sell |
10,526
-2,000
| -16% | -$79.8K | 0.02% | 943 |
|
|
2019
Q2 | $545K | Buy |
12,526
+2,100
| +20% | +$89.2K | 0.03% | 715 |
|
|
2019
Q1 | $397K | Buy |
+10,426
| New | +$407K | 0.02% | 831 |
|
|
2018
Q1 | – | Sell |
-8,300
| Closed | -$378K | – | 1698 |
|
|
2017
Q4 | $378K | Buy |
+8,300
| New | +$329K | 0.02% | 999 |
|
|
2017
Q2 | – | Sell |
-48,200
| Closed | -$2.2M | – | 1645 |
|
|
2017
Q1 | $2.2M | Sell |
48,200
-8,900
| -16% | -$385K | 0.1% | 284 |
|
|
2016
Q4 | $1.84M | Buy |
57,100
+41,000
| +255% | +$1.37M | 0.11% | 294 |
|
|
2016
Q3 | $550K | Sell |
16,100
-64,005
| -80% | -$2.51M | 0.18% | 177 |
|
|
2016
Q2 | $2.7M | Buy |
+80,105
| New | +$3.94M | 0.13% | 220 |
|
|
2016
Q1 | – | Sell |
-33,407
| Closed | -$2.56M | – | 1583 |
|
|
2015
Q4 | $2.56M | Sell |
33,407
-10,727
| -24% | -$607K | 0.12% | 218 |
|
|
2015
Q3 | $1.81M | Buy |
44,134
+34,722
| +369% | +$2.13M | 0.07% | 409 |
|
|
2015
Q2 | $665K | Sell |
9,412
-26,219
| -74% | -$2.06M | 0.02% | 887 |
|
|
2015
Q1 | $3.17M | Sell |
35,631
-24,068
| -40% | -$2.44M | 0.11% | 250 |
|
|
2014
Q4 | $5.29M | Buy |
59,699
+25,729
| +76% | +$2.43M | 0.2% | 119 |
|
|
2014
Q3 | $3.29M | Buy |
33,970
+22,505
| +196% | +$2.19M | 0.15% | 188 |
|
|
2014
Q2 | $1.05M | Sell |
11,465
-23,238
| -67% | -$1.77M | 0.05% | 488 |
|
|
2014
Q1 | $2.43M | Buy |
34,703
+22,628
| +187% | +$1.54M | 0.13% | 206 |
|
|
2013
Q4 | $694K | Sell |
12,075
-29,419
| -71% | -$1.55M | 0.04% | 641 |
|
|
2013
Q3 | $2M | Sell |
41,494
-9,235
| -18% | -$337K | 0.11% | 269 |
|
|
2013
Q2 | $1.47M | Buy |
+50,729
| New | +$1.47M | 0.05% | 488 |
|
Other funds holding PCRX
PC
FCM
SIMG
RSCM